Apteka Usteckasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-04-16
Share capital
750,000.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-74072-27007-DARGB-17

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 12 days late).

  • 202510/05/2026
  • 202422/05/2025
  • 202324/04/2024
  • 202222/06/2023
  • 202127/07/2022
  • 202031/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.39mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 314.21kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 5.00mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.91mMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Ustecka has been an NFZ healthcare provider since 2019. In 2026 it is performing 2 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciespomorskie2USD 0.00

Authorized Representatives

Aleksandra Olszacka – Vice President of the Management Board
Bożena Helena Szymańska – President of the Management Board
Katarzyna Nockowska Stańczak – Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, the validity of declarations submitted on behalf of the company requires the joint action of two members of the management board or a member of the management board jointly with a commercial proxy. The commercial proxy submits declarations on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

OwnerSharesShare valueStake
1,140$153,970.8376%
360$48,622.3724%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-02-11.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,356
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,352
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,041

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2024-06-03Address change
2024-06-03Share capital increase
2024-06-03PKD change
2018-09-11PKD change
2009-12-29Switch to PKD 2007

FAQ

Last updated: 2026-05-10